Search

FDA

Advertorial: Pillars Not Fillers

Dr Dev Patel discusses treating young patients and why he believes the term ‘filler’ is no longer relevant, especially when looking to achieve natural looking results for this patient demographic

Read More »

New toxin accepted for review

Biopharmaceutical company Hugel America and aesthetic manufacturer Croma-Pharma has unveiled that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for letibotulinumtoxinA as a treatment for glabellar lines.

Read More »